Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)
222.00
+2.00 (0.91%)
At close: Feb 12, 2026
NSE:MADHAVBAUG Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 55.38 | 23.61 | 23.73 | 17.64 | 25.61 | 9.05 |
Short-Term Investments | 93.29 | 149.55 | 159.87 | 137.95 | 166.07 | - |
Cash & Short-Term Investments | 148.68 | 173.16 | 183.59 | 155.59 | 191.68 | 9.05 |
Cash Growth | -23.35% | -5.68% | 18.00% | -18.83% | 2018.51% | -14.67% |
Accounts Receivable | 78.39 | 75.39 | 60.5 | 59.9 | 35.59 | 26.38 |
Other Receivables | - | 6.05 | 5.18 | - | - | - |
Receivables | 107.68 | 82.13 | 69.26 | 62.22 | 37.49 | 26.38 |
Inventory | 33.91 | 37.56 | 41.14 | 34.14 | 15.01 | 16.15 |
Prepaid Expenses | - | 3.16 | 13.63 | 7.69 | 0.79 | 0.46 |
Other Current Assets | - | 6.85 | 5.89 | 18.21 | 27.3 | 19.86 |
Total Current Assets | 290.27 | 302.85 | 313.52 | 277.84 | 272.27 | 71.9 |
Property, Plant & Equipment | 211.95 | 214.46 | 230.25 | 201.06 | 171.95 | 170.82 |
Long-Term Investments | 124.13 | 63.6 | 20.03 | 15.35 | 48.81 | 0.1 |
Goodwill | - | 46.52 | 46.52 | - | - | - |
Other Intangible Assets | 130.62 | 88.22 | 29.52 | 25.13 | 10.44 | 4.54 |
Long-Term Deferred Tax Assets | 0.06 | - | 0.73 | 0.75 | -0.48 | 0.41 |
Other Long-Term Assets | 63.09 | 51.45 | 56.58 | 27.92 | 14.08 | 10.29 |
Total Assets | 820.12 | 767.09 | 697.14 | 548.84 | 517.07 | 258.06 |
Accounts Payable | 52.46 | 68.63 | 71 | 89.65 | 73.79 | 67.48 |
Accrued Expenses | - | 18.58 | 22.89 | 24.83 | 31.83 | 23.99 |
Short-Term Debt | 6.31 | 14.6 | 16.78 | 1.34 | 10.63 | 10.16 |
Current Income Taxes Payable | - | 4.25 | - | - | 12.18 | 6.18 |
Other Current Liabilities | 51.79 | 6.19 | 5.52 | 12.94 | 14.16 | 31.41 |
Total Current Liabilities | 110.56 | 112.25 | 116.19 | 128.76 | 142.59 | 139.22 |
Pension & Post-Retirement Benefits | - | 13.87 | 10.63 | 12.61 | 11.63 | 10.39 |
Long-Term Deferred Tax Liabilities | - | 0.49 | - | - | - | - |
Other Long-Term Liabilities | 32.24 | 15.12 | 14.28 | 2.92 | 4.02 | 10.78 |
Total Liabilities | 142.8 | 141.72 | 141.1 | 144.3 | 158.24 | 160.39 |
Common Stock | 105.16 | 105.2 | 105.16 | 105.14 | 105.14 | 0.45 |
Additional Paid-In Capital | - | 191.08 | 191.08 | 191.08 | 191.08 | 1.11 |
Retained Earnings | - | 196.96 | 125.48 | 108.31 | 62.61 | 96.11 |
Comprehensive Income & Other | 572.16 | 132.12 | 134.31 | - | - | - |
Total Common Equity | 677.32 | 625.36 | 556.03 | 404.53 | 358.83 | 97.67 |
Minority Interest | -0 | 0.01 | 0.01 | 0.02 | - | - |
Shareholders' Equity | 677.31 | 625.37 | 556.04 | 404.54 | 358.83 | 97.67 |
Total Liabilities & Equity | 820.12 | 767.09 | 697.14 | 548.84 | 517.07 | 258.06 |
Total Debt | 6.31 | 14.6 | 16.78 | 1.34 | 10.63 | 10.16 |
Net Cash (Debt) | 142.37 | 158.56 | 166.81 | 154.25 | 181.05 | -1.12 |
Net Cash Growth | -22.05% | -4.95% | 8.14% | -14.80% | - | - |
Net Cash Per Share | 13.46 | 12.85 | 13.52 | 14.67 | 17.22 | -0.16 |
Filing Date Shares Outstanding | 10.6 | 10.52 | 10.51 | 10.51 | 10.51 | 7.74 |
Total Common Shares Outstanding | 10.6 | 10.52 | 10.51 | 10.51 | 10.51 | 6.98 |
Working Capital | 179.7 | 190.6 | 197.33 | 149.08 | 129.68 | -67.32 |
Book Value Per Share | 63.93 | 59.44 | 52.89 | 38.48 | 34.13 | 14.00 |
Tangible Book Value | 546.7 | 490.62 | 479.99 | 379.39 | 348.39 | 93.13 |
Tangible Book Value Per Share | 51.60 | 46.64 | 45.65 | 36.09 | 33.14 | 13.35 |
Land | - | 3.42 | 3.42 | 3.24 | 3.24 | 3.24 |
Buildings | - | 115.54 | 108.67 | 97.27 | 93 | 90.65 |
Machinery | - | 259.33 | 237.64 | 189.06 | 150.89 | 144.45 |
Construction In Progress | - | - | 17.6 | 16.72 | 12.31 | 3.81 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.